Relief of Urinary Symptom Burden after Primary Prostate Cancer Treatment

Author:

Chang Peter1,Regan Meredith M.2,Ferrer Montserrat345,Guedea Ferran6,Patil Dattatraya7,Wei John T.8,Hembroff Larry A.9,Michalski Jeff M.10,Saigal Chris S.11,Litwin Mark S.1112,Hamstra Daniel A.13,Kaplan Irving D.14,Ciezki Jay P.15,Klein Eric A.16,Kibel Adam S.17,Sandler Howard M.18,Dunn Rodney L.8,Crociani Catrina M.1,Sanda Martin G.7,

Affiliation:

1. Department of Surgery, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts

2. Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts

3. Health Services Research Unit, Hospital del Mar Research Institute, Barcelona, Spain

4. CIBER Epidemiología y Salud Pública, Barcelona, Spain

5. Universitat Autònoma de Barcelona, Barcelona, Spain

6. Department of Radiation Oncology, Institut Català d’Oncologia, L’Hospitalet de Llobregat, Barcelona, Spain

7. Department of Urology, Emory University School of Medicine, Atlanta, Georgia

8. Department of Urology, University of Michigan, Ann Arbor, Michigan

9. Office for Survey Research, Institute for Public Policy and Social Research, Michigan State University, East Lansing, Michigan

10. Department of Radiation Oncology, Washington University, St. Louis, Missouri

11. Department of Urology, UCLA Center for Health Sciences, Los Angeles, California

12. Department of Health Policy and Management, UCLA Center for Health Sciences, Los Angeles, California

13. Texas Center for Proton Therapy, Irving, Texas

14. Department of Radiation Oncology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts

15. Department of Radiation Oncology, Cleveland Clinic, Cleveland, Ohio

16. Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio

17. Division of Urology, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts

18. Department of Radiation Oncology, Cedars-Sinai Medical Center, Los Angeles, California

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3